Hybrid single-chain plasminogen activators

Details Hybrid single-chain plasminogen activators Hybrid single-chain plasminogen activators

C - Chemistry, Metallurgy

12

N

195/1.22, 167/10

C12N 15/62 (2006.01) A61K 38/49 (2006.01) C07K 19/00 (2006.01) C12N 9/72 (2006.01) C12N 15/10 (2006.01) C12N 15/58 (2006.01) C12N 15/79 (2006.01) C12P 21/02 (2006.01)

Patent

CA 1341479

Novel single-chain hybrid plasminogen activators having an amino acid sequence composed of at least two subsequences corresponding in amino acid identity and number to subsequences of human t-PA and of human u-PA, and mutants thereof in which at least one of the N-glycosylation sites is modified such that glycosylation cannot take place at these sites exhibit valuable pharmacological properties. The hybrid plasminogen activators are produced by recombinant DNA technology.

553406

Affiliated with

Also associated with

Rating

Hybrid single-chain plasminogen activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid single-chain plasminogen activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid single-chain plasminogen activators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1175601